Candesartan Cilexetil Drug Global Market Report 2025
상품코드:1760497
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
칸데사르탄실렉세틸 의약품 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 5.8%의 CAGR로 20억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 제네릭 의약품의 가용성 확대, 생활습관병 유병률 증가, 저렴한 고혈압 치료에 대한 정부의 노력, 심혈관질환의 유병률 증가, 병용요법 채택 확대 등에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 칸데살탄 제네릭으로의 전환, 복합제 개발, 고혈압 모니터링을 위한 디지털 헬스 통합, 환자의 순응도 향상, 새로운 전달 메커니즘에 대한 연구 증가 등을 꼽을 수 있습니다.
고혈압 유병률의 증가는 향후 칸데사르탄실렉세틸 의약품 시장의 성장을 견인할 것으로 예상됩니다. 일반적으로 고혈압으로 알려진 고혈압은 동맥벽에 대한 혈액의 힘이 지속적으로 너무 높은 상태이며, 일반적으로 130/80mmHg 이상의 수치로 정의됩니다. 고혈압의 유병률 증가는 불규칙한 식습관, 운동 부족, 과도한 스트레스 등 건강에 해로운 생활습관에 기인합니다. 칸데사르탄실렉세틸은 혈관을 수축시키는 호르몬인 안지오텐신 II의 작용을 억제하여 혈관을 이완시키고 혈압을 낮춰 고혈압 치료에 도움을 줍니다. 예를 들어, 2024년 10월 미국 질병통제예방센터(CDC)는 2021년 8월-2023년 8월 사이 18-39세에서 40-59세 사이 고혈압 유병률이 124.48%, 40-59세에서 60세 이상은 36.38% 상승해 고혈압 유병률이 유의미하게 증가했다고 보고했습니다. 따라서 고혈압에 대한 부담이 증가하면서 칸데사르탄실렉세틸에 대한 수요가 증가하고 있습니다.
심혈관질환의 유병률 증가는 향후 칸데사르탄실렉세틸 의약품 시장의 성장을 촉진할 것으로 예상됩니다. 심혈관질환은 심장과 혈관에 영향을 미치고 심장 기능을 손상시키는 건강 문제입니다. 심혈관질환의 증가는 주로 운동 부족으로 인해 비만, 고혈압, 심혈관 건강 악화로 이어져 결국 심장과 순환기 계통의 효율성을 떨어뜨립니다. 칸데사르탄실렉세틸은 혈압을 낮추고 심장의 부담을 완화하며 심부전, 뇌졸중, 신장 손상과 같은 합병증의 위험을 감소시켜 심혈관질환 관리에 도움이 됩니다. 예를 들어, 2025년 1월 영국에 기반을 둔 심혈관 연구 기관인 British Heart Foundation은 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 그 중 남성이 약 400만 명, 여성이 약 360만 명에 달한다고 보고했습니다. 이러한 질병은 영국 전체 사망자의 약 27%를 차지하며, 연간 17만 명 이상, 하루 약 480명이 사망하고 있습니다. 결과적으로 심혈관질환의 유병률 증가가 칸데사르탄실렉세틸 의약품 시장의 성장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 칸데사르탄실렉세틸 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 칸데사르탄실렉세틸 의약품 시장 : 성장률 분석
세계의 칸데사르탄실렉세틸 의약품 시장 실적 : 규모와 성장, 2019-2024년
세계의 칸데사르탄실렉세틸 의약품 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 칸데사르탄실렉세틸 의약품 전체 시장(TAM)
제6장 시장 세분화
세계의 칸데사르탄실렉세틸 의약품 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
정제
캡슐
기타
세계의 칸데사르탄실렉세틸 의약품 시장 : 적응증별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
고혈압
심부전
당뇨병성 신증
좌심실 비대
세계의 칸데사르탄실렉세틸 의약품 시장 : 용량 강도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
4 MG
8 MG
16 MG
32 MG
세계의 칸데사르탄실렉세틸 의약품 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
헬스케어 시설
세계의 칸데사르탄실렉세틸 의약품 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
성인
아동·청소년
세계의 칸데사르탄실렉세틸 의약품 시장 : 정제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
즉방정
서방정
분산정
츄어블정
세계의 칸데사르탄실렉세틸 의약품 시장 : 캡슐 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
하드 젤라틴 캡슐
소프트 젤라틴 캡슐
서방형 캡슐
세계의 칸데사르탄실렉세틸 의약품 시장 : 기타 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구 현탁액
주사제
배합제
제7장 지역별·국가별 분석
세계의 칸데사르탄실렉세틸 의약품 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 칸데사르탄실렉세틸 의약품 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
칸데사르탄실렉세틸 의약품 시장 : 경쟁 구도
칸데사르탄실렉세틸 의약품 시장 : 기업 개요
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
GSK plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH
Sandoz Group AG
Viatris Inc.
Sun Pharmaceutical Industries Limited
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Cipla Limited
Zydus Lifesciences Ltd.
Hetero Drugs Limited
Torrent Pharmaceuticals Limited
Macleods Pharmaceuticals Ltd.
Alembic Pharmaceuticals Limited
Oubari Pharmaceutical Co.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
칸데사르탄실렉세틸 의약품 시장 2029년 : 새로운 기회를 제공하는 국가
칸데사르탄실렉세틸 의약품 시장 2029년 : 새로운 기회를 제공하는 부문
칸데사르탄실렉세틸 의약품 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Candesartan cilexetil is an angiotensin II receptor antagonist primarily used to treat high blood pressure and heart failure. It works by blocking the effects of angiotensin II, helping to relax blood vessels and lower blood pressure.
The main product types of candesartan cilexetil include tablets, capsules, and other forms. Tablets are solid dosage forms that typically consist of a mixture of active pharmaceutical ingredients and excipients, compressed into a small, convenient shape. Candesartan cilexetil is used for multiple indications, including hypertension, heart failure, diabetic nephropathy, and left ventricular hypertrophy. The available dosage strengths are 4 mg, 8 mg, 16 mg, and 32 mg. The drug is distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and healthcare facilities. It is used for a range of applications in adults, children, and adolescents.
The candesartan cilexetil drug market research report is one of a series of new reports from The Business Research Company that provides candesartan cilexetil drug market statistics, including the candesartan cilexetil drug industry global market size, regional shares, competitors with the candesartan cilexetil drug market share, detailed candesartan cilexetil drug market segments, market trends, and opportunities, and any further data you may need to thrive in the candesartan cilexetil drug industry. This candesartan cilexetil drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The candesartan cilexetil drug market size has grown strongly in recent years. It will grow from $1.57 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period can be attributed to the rising prevalence of hypertension, the increasing geriatric population, a higher incidence of chronic diseases, a greater focus on preventative care, and the growing healthcare expenditure.
The candesartan cilexetil drug market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to the expansion of generic drug availability, the rising incidence of lifestyle-related diseases, government initiatives for affordable hypertension care, the increasing prevalence of cardiovascular diseases, and the growing adoption of combination therapies. Key trends in the forecast period include a shift toward generic candesartan formulations, the development of fixed-dose combination drugs, integration of digital health for hypertension monitoring, a growing focus on patient compliance, and increasing research on novel delivery mechanisms.
The rising prevalence of hypertension is expected to drive the growth of the candesartan cilexetil drug market in the future. Hypertension, commonly known as high blood pressure, is a condition in which the force of blood against the artery walls is consistently too high, typically defined by a reading of 130/80 mmHg or higher. The increasing prevalence of hypertension is largely attributed to unhealthy lifestyle choices, including poor diet, insufficient physical activity, and high-stress levels. Candesartan cilexetil helps manage hypertension by blocking the action of angiotensin II, a hormone that narrows blood vessels, thereby relaxing the vessels and lowering blood pressure. For instance, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a significant increase in hypertension prevalence, rising by 124.48% from the 18-39 age group to the 40-59 age group, and by 36.38% from the 40-59 age group to individuals aged 60 and above, between August 2021 and August 2023. Therefore, the rising burden of hypertension is boosting the demand for candesartan cilexetil.
The rising incidence of cardiovascular disorders is expected to fuel the growth of the candesartan cilexetil drug market moving forward. Cardiovascular disorders are health issues that affect the heart or blood vessels, impairing heart function. The increase in cardiovascular disorders is mainly due to a lack of physical activity, which can lead to obesity, high blood pressure, and poor cardiovascular health, ultimately reducing the heart and circulatory system's efficiency. Candesartan cilexetil helps manage cardiovascular conditions by lowering blood pressure, easing the strain on the heart, and reducing the risk of complications such as heart failure, stroke, and kidney damage. For example, in January 2025, the British Heart Foundation, a UK-based cardiovascular research organization, reported that about 7.6 million people in the UK suffer from heart and circulatory diseases, including around 4 million men and 3.6 million women. These diseases contribute to nearly 27% of all deaths in the country, leading to over 170,000 fatalities annually, or about 480 deaths per day. As a result, the increasing prevalence of cardiovascular disorders is driving the growth of the candesartan cilexetil drug market.
Key players in the candesartan cilexetil drug market are focusing on developing innovative formulations, such as combination therapies with other antihypertensive medications and extended-release versions, to enhance patient adherence and improve treatment outcomes. Hypertension treatment includes medications, lifestyle changes, and other interventions aimed at lowering blood pressure to reduce the risk of complications such as heart disease, stroke, and kidney damage. For instance, in March 2025, Scienture Inc., a US-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its New Drug Application (NDA) for SCN-102, branded as Arbli, a losartan potassium oral suspension (10 mg/mL). This angiotensin II receptor blocker (ARB) formulation offers an alternative for patients who have difficulty swallowing tablets, particularly among pediatric and geriatric populations. The launch of this product highlights the growing interest in alternative dosage forms in the antihypertensive market and signals a shift toward more personalized, patient-friendly drug delivery systems.
Major players in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.
North America was the largest region in the candesartan cilexetil drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in candesartan cilexetil drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the candesartan cilexetil drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The candesartan cilexetil drug market consists of sales of atacand, candesartan tablets, and oral tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Candesartan Cilexetil Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on candesartan cilexetil drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for candesartan cilexetil drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The candesartan cilexetil drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Tablets; Capsules; Other Product Types
2) By Indication: Hypertension; Heart Failure; Diabetic Nephropathy; Left Ventricular Hypertrophy
3) By Dosage Strength: 4 MG; 8 MG; 16 MG; 32 MG
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Healthcare Facilities
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Candesartan Cilexetil Drug Market Characteristics
3. Candesartan Cilexetil Drug Market Trends And Strategies
4. Candesartan Cilexetil Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Candesartan Cilexetil Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Candesartan Cilexetil Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Candesartan Cilexetil Drug Market Growth Rate Analysis
5.4. Global Candesartan Cilexetil Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Candesartan Cilexetil Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Candesartan Cilexetil Drug Total Addressable Market (TAM)
6. Candesartan Cilexetil Drug Market Segmentation
6.1. Global Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Other Product Types
6.2. Global Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Heart Failure
Diabetic Nephropathy
Left Ventricular Hypertrophy
6.3. Global Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
4 MG
8 MG
16 MG
32 MG
6.4. Global Candesartan Cilexetil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Healthcare Facilities
6.5. Global Candesartan Cilexetil Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Children And Adolescent
6.6. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Extended-Release Tablets
Dispersible Tablets
Chewable Tablets
6.7. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hard Gelatin Capsules
Soft Gelatin Capsules
Modified-Release Capsules
6.8. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Suspensions
Injectable Formulations
Combination Drug Formulations
7. Candesartan Cilexetil Drug Market Regional And Country Analysis
7.1. Global Candesartan Cilexetil Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Candesartan Cilexetil Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Candesartan Cilexetil Drug Market
8.1. Asia-Pacific Candesartan Cilexetil Drug Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Candesartan Cilexetil Drug Market
9.1. China Candesartan Cilexetil Drug Market Overview
9.2. China Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Candesartan Cilexetil Drug Market
10.1. India Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Candesartan Cilexetil Drug Market
11.1. Japan Candesartan Cilexetil Drug Market Overview
11.2. Japan Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Candesartan Cilexetil Drug Market
12.1. Australia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Candesartan Cilexetil Drug Market
13.1. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Candesartan Cilexetil Drug Market
14.1. South Korea Candesartan Cilexetil Drug Market Overview
14.2. South Korea Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Candesartan Cilexetil Drug Market
15.1. Western Europe Candesartan Cilexetil Drug Market Overview
15.2. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Candesartan Cilexetil Drug Market
16.1. UK Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Candesartan Cilexetil Drug Market
17.1. Germany Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Candesartan Cilexetil Drug Market
18.1. France Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Candesartan Cilexetil Drug Market
19.1. Italy Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Candesartan Cilexetil Drug Market
20.1. Spain Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Candesartan Cilexetil Drug Market
21.1. Eastern Europe Candesartan Cilexetil Drug Market Overview
21.2. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Candesartan Cilexetil Drug Market
22.1. Russia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Candesartan Cilexetil Drug Market
23.1. North America Candesartan Cilexetil Drug Market Overview
23.2. North America Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Candesartan Cilexetil Drug Market
24.1. USA Candesartan Cilexetil Drug Market Overview
24.2. USA Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Candesartan Cilexetil Drug Market
25.1. Canada Candesartan Cilexetil Drug Market Overview
25.2. Canada Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Candesartan Cilexetil Drug Market
26.1. South America Candesartan Cilexetil Drug Market Overview
26.2. South America Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Candesartan Cilexetil Drug Market
27.1. Brazil Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Candesartan Cilexetil Drug Market
28.1. Middle East Candesartan Cilexetil Drug Market Overview
28.2. Middle East Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Candesartan Cilexetil Drug Market
29.1. Africa Candesartan Cilexetil Drug Market Overview
29.2. Africa Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Candesartan Cilexetil Drug Market Competitive Landscape And Company Profiles
30.1. Candesartan Cilexetil Drug Market Competitive Landscape
30.2. Candesartan Cilexetil Drug Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis
31. Candesartan Cilexetil Drug Market Other Major And Innovative Companies
31.1. Takeda Pharmaceutical Company Limited
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Boehringer Ingelheim International GmbH
31.4. Sandoz Group AG
31.5. Viatris Inc.
31.6. Sun Pharmaceutical Industries Limited
31.7. Aurobindo Pharma Limited
31.8. Dr. Reddy's Laboratories Limited
31.9. Cipla Limited
31.10. Zydus Lifesciences Ltd.
31.11. Hetero Drugs Limited
31.12. Torrent Pharmaceuticals Limited
31.13. Macleods Pharmaceuticals Ltd.
31.14. Alembic Pharmaceuticals Limited
31.15. Oubari Pharmaceutical Co.
32. Global Candesartan Cilexetil Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Candesartan Cilexetil Drug Market
34. Recent Developments In The Candesartan Cilexetil Drug Market
35. Candesartan Cilexetil Drug Market High Potential Countries, Segments and Strategies
35.1 Candesartan Cilexetil Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Candesartan Cilexetil Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Candesartan Cilexetil Drug Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
